- Home
- KRC vs ACLX Comparison
KRC vs ACLX Comparison
Compare KRC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRC
- ACLX
- Stock Information
- Founded
- KRC 1947
- ACLX 2015
- Country
- KRC United States
- ACLX United States
- Employees
- KRC N/A
- ACLX N/A
- Industry
- KRC Real Estate Investment Trusts
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- KRC Real Estate
- ACLX Health Care
- Exchange
- KRC Nasdaq
- ACLX Nasdaq
- Market Cap
- KRC N/A
- ACLX 3.8B
- IPO Year
- KRC 1997
- ACLX 2022
- Fundamental
- Price
- KRC $36.83
- ACLX $68.36
- Analyst Decision
- KRC Hold
- ACLX Strong Buy
- Analyst Count
- KRC 11
- ACLX 14
- Target Price
- KRC $37.73
- ACLX $111.42
- AVG Volume (30 Days)
- KRC 1.3M
- ACLX 497.6K
- Earning Date
- KRC 07-28-2025
- ACLX 08-07-2025
- Dividend Yield
- KRC 5.88%
- ACLX N/A
- EPS Growth
- KRC N/A
- ACLX N/A
- EPS
- KRC 1.68
- ACLX N/A
- Revenue
- KRC $1,127,892,000.00
- ACLX $76,809,000.00
- Revenue This Year
- KRC N/A
- ACLX N/A
- Revenue Next Year
- KRC $1.63
- ACLX $108.81
- P/E Ratio
- KRC $21.86
- ACLX N/A
- Revenue Growth
- KRC 1.11
- ACLX N/A
- 52 Week Low
- KRC $27.07
- ACLX $47.86
- 52 Week High
- KRC $43.78
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- KRC 64.50
- ACLX 61.59
- Support Level
- KRC $36.20
- ACLX $67.58
- Resistance Level
- KRC $37.58
- ACLX $71.53
- Average True Range (ATR)
- KRC 0.95
- ACLX 2.12
- MACD
- KRC 0.09
- ACLX 0.34
- Stochastic Oscillator
- KRC 80.72
- ACLX 84.40
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.